Elite Pharmaceuticals Reports $40.1 Million in Revenue and $17.3 Million Net Income for Q2 FY2027
Generic Drugmaker Posts $40.1 Million in Quarterly Revenue and $17.3 Million in Net Income Attributable to Common Shareholders Related Stocks: ELTP ,
Generic Drugmaker Posts $40.1 Million in Quarterly Revenue and $17.3 Million in Net Income Attributable to Common Shareholders Related Stocks: ELTP ,